查詢結果分析
相關文獻
- Determination of Unbound Hesperetin in Rat Blood and Brain by Microdialysis Coupled to Microbore Liquid Chromatography
- 選擇性血清素再吸收抑制劑
- Fluvoxamine對Clozapine藥物動力學之影響
- 藥物動力學在臨床上之應用:藥物動力學服務
- 碳酸酐酶抑制劑6-Hydroxyethoxy-2-benzothiazole Sulfonamide靜脈注射後之兔眼藥物動力學
- 碳酸酐酶抑制劑6-Hydroxyethoxyzolamide局部點眼後之兔眼藥物動力學
- 新抗癲癇藥
- Pharmacokinetics and Brain Regional Distribution of caffeine in Rats
- 分析樣品前處理技術--微透析分析技術
- 口服Ketorolac藥物動力學特色
頁籤選單縮合
題 名 | Determination of Unbound Hesperetin in Rat Blood and Brain by Microdialysis Coupled to Microbore Liquid Chromatography=結合微透析與微管液相層析技術偵測大白鼠血液與腦部之非結合態橙皮素 |
---|---|
作 者 | 蔡東湖; 陳嬿妃; | 書刊名 | 藥物食品分析 |
卷 期 | 8:4 2000.12[民89.12] |
頁 次 | 頁331-336 |
分類號 | 415.12 |
關鍵詞 | 橙皮素; 微透析; 藥物動力學; 微管高效液相層析; Hesperetin; Microdialysis; Pharmacokinetics; Microbore HPLC; |
語 文 | 英文(English) |
中文摘要 | 本實驗應用一套快速、靈敏的微管高效液相層析技術,偵測大白鼠腦部和血液中的非結合態橙皮素,此技術已發展應用於藥品的採樣。高效液相層析系統中,使用逆相碳18微管柱(100 × 1 mm I.D., 粒徑5 μm),移動相為acetonitrile-methanol-20 mM monosodium phosphate (pH 5.3) (40:10:50, v/v/v),流速0.05 mL/min,紫外光偵測波長設定在最大吸收值288 nm 。微透析探針分別插入雄性大白鼠的頸靜脈(即進入右心房)和腦部紋狀體。實驗方法是將橙皮素注入六隻大白鼠的股靜脈,每隻大白鼠之注射劑量為50 mg/kg,然後分別收集血液與腦部之微透析液並進行分析。根據所得之個體數據可計算藥物動力學參數,並求得橙皮素透析液濃度與時間之關係。 |
英文摘要 | A rapid and sensitive microbore high-performance liquid chromatography (HPLC) coupled to microdialysis technique for simultaneous determination of unbound hesperetin in rat blood and brain has been developed. The HPLC assay was carried out using a microbore reversed-phase C-18 column (100 × 1 mm I.D., 5 μm particle size). The mobile phase used was acetonitrile-methanol-20 mM monosodium phosphate (pH 5.3) (40:10:50, v/v/v) for hesperetin at a flow-rate of 0.05 mL/min. The assay was performed by monitoring the wavelength of maximum UV absorbance at 288 nm. Microdialysis probes were inserted into the jugular vein/right atrium and brain striatum of male Sprague-Dawley rats. Hesperetin (50 mg/kg, i.v., n=6) was administered via the femoral vein, and microdialysates were collected from both sites and assayed by the validated microbore scale HPLC method. Pharmacokinetic parameters were calculated from the corrected data for dialysate concentrations of hesperetin versus time. |
本系統中英文摘要資訊取自各篇刊載內容。